FIGURE 1
FROM:
MCM immunocytochemistry as a first line cervical screening test in developing countries: a prospective cohort study in a regional cancer centre in India
G Mukherjee, B Muralidhar, U D Bafna, R A Laskey and N Coleman
BACK TO ARTICLEFigure 1.

Flow chart summarising study design and results. *For three cases in this group, the Pap smear was deemed unsatisfactory, rather than negative, on review.
